Whiteswell
WhiteSwell is dedicated to advancing treatment of acute decompensated heart failure .
Whiteswell has raised €26M across 1 funding round from 1 investor, most recently a Series B round in Dec 2018. Based in Ballybrit, Ireland; founded 2014; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€26M
€26,441,036
Funding rounds
1
Investors
1
distinct backers
Active since
2018-12
latest 2018-12
Funding by year
EUR raised per yearWhiteswell — funding by year — interactive chart.
Data table
| Whiteswell — funding by year | |
|---|---|
| 2018 | €26M |
Signals
High confidenceRaise-next likelihood9
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2018-12-13 | Series B | €26M | RA Capital Management | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Wayflyer€2.1BIreland · E-commerce
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
Global coverage: FundingData